These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25821550)

  • 21. Adverse cutaneous reactions to antituberculosis drugs.
    Holdiness MR
    Int J Dermatol; 1985 Jun; 24(5):280-5. PubMed ID: 2410379
    [No Abstract]   [Full Text] [Related]  

  • 22. In reply.
    Reves RR
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):495. PubMed ID: 25860012
    [No Abstract]   [Full Text] [Related]  

  • 23. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe and effective treatment for patients with isoniazid drug resistance.
    Phillips PP; Lipman MC
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):494-5. PubMed ID: 25860010
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse reactions to pyrazinamide.
    Ribi C; Hauser C
    Allergy; 2002 Oct; 57(10):964-5. PubMed ID: 12269954
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed-type hypersensitivity reaction to ethambutol and isoniazid.
    Bakkum RS; Waard-Van Der Spek FB; Thio HB
    Contact Dermatitis; 2002 Jun; 46(6):359. PubMed ID: 12190628
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
    Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
    Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
    Indian J Tuberc; 2007 Apr; 54(2):84-90. PubMed ID: 17575680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
    González C; Sáenz C; Herrmann E; Jajati M; Kaplan P; Monzón D
    Medicina (B Aires); 2012; 72(5):371-9. PubMed ID: 23089112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
    Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
    Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrazinamide-induced lichenoid photodermatitis.
    Choonhakarn C; Janma J
    J Am Acad Dermatol; 1999 Apr; 40(4):645-6. PubMed ID: 10188694
    [No Abstract]   [Full Text] [Related]  

  • 35. [Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
    Göpel B; Götte K
    Laryngorhinootologie; 2005 Aug; 84(8):610-9; quiz 621-2. PubMed ID: 16080064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
    Radal M; Jonville-Bera AP; Van-Egroo C; Carré P; Lemarié E; Autret E
    Rev Mal Respir; 1998 Jun; 15(3):305-6. PubMed ID: 9677642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between carbamazepine and antituberculosis agents.
    Fleenor ME; Harden JW; Curtis G
    Chest; 1991 Jun; 99(6):1554. PubMed ID: 2036861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.